CoChat

High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia

Open access
Cao, Chuanhai, Loewenstein, David A., Lin, Xiaoyang, Zhang, Chi, Wang, Li, Duara, Ranjan, Wu, Yougui, Giannini, Alessandra, Bai, Ge, Cai, Jianfeng, Greig, Maria, Schofield, Elizabeth, Ashok, Raj, Small, Brent, Potter, Huntington, Arendash, Gary W. · 2012 · Journal of Alzheimer's Disease
Cited by 133

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Although both human epidemiologic and animal model studies have suggested that caffeine/coffee protects against Alzheimer's disease, direct human evidence for this premise has been lacking. In the present case-control study, two separate cohorts consisting of 124 total individuals (65-88 years old) were cognitively assessed and a blood sample taken for caffeine/biomarker analysis. Subjects were then monitored for cognitive status over the ensuing 2-4 year period to determine the extent to which initial plasma caffeine/biomarkers levels would be predictive of changes in cognitive status. Plasma caffeine levels at study onset were substantially lower (-51%) in mild cognitive impairment (MCI) subjects who later progressed to dementia (MCI→DEM) compared to levels in stable MCI subjects (MCI→MCI). Moreover, none of the MCI→DEM subjects had initial blood caffeine levels that were above a critical level of 1200 ng/ml, while half of stable MCI→MCI subjects had blood caffeine levels higher than that critical level. Thus, plasma caffeine levels greater than 1200 ng/ml (≈6 μM) in MCI subjects were associated with no conversion to dementia during the ensuing 2-4 year follow-up period. Among the 11 cytokines measured in plasma, three of them (GCSF, IL-10, and IL-6) were decreased in MCI→DEM subjects, but not in stable MCI→MCI subjects with high plasma caffeine levels. Coffee would appear to be the major or perhaps only source of caffeine for such stable MCI patients. This case-control study provides the first direct evidence that caffeine/coffee intake is associated with a reduced risk of dementia or delayed onset, particularly for those who already have MCI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-2012-111781

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 133

Metadata

Authors
Cao, C., Loewenstein, D. A., Lin, X., Zhang, C., Wang, L., Duara, R., Wu, Y., Giannini, A., Bai, G., Cai, J., Greig, M., Schofield, E., Ashok, R., Small, B., Potter, H., & Arendash, G. W.
Venue
Journal of Alzheimer's Disease
Published
2012-06-04
Volume
30
Issue
3
Pages
559-572
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2111549050
Cited by
133
References
18
FWCI
9.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia. https://app.cochat.ai/papers/10.3233/jad-2012-111781
The paper
Cao, C., Loewenstein, D. A., Lin, X., Zhang, C., Wang, L., Duara, R., Wu, Y., Giannini, A., Bai, G., Cai, J., Greig, M., Schofield, E., Ashok, R., Small, B., Potter, H., & Arendash, G. W. (2012). High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-2012-111781

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.